|
TSN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.609400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.004600E-01 |
| Normal-vs-Stage2 |
9.834600E-01 |
| Normal-vs-Stage3 |
2.434600E-01 |
| Normal-vs-Stage4 |
9.341000E-01 |
| Stage1-vs-Stage2 |
5.443800E-01 |
| Stage1-vs-Stage3 |
6.078400E-01 |
| Stage1-vs-Stage4 |
4.492600E-01 |
| Stage2-vs-Stage3 |
4.217800E-01 |
| Stage2-vs-Stage4 |
9.392000E-01 |
| Stage3-vs-Stage4 |
2.726800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.534800E-01 |
| Normal-vs-AfricanAmerican |
2.205400E-01 |
| Normal-vs-Asian |
2.812000E-01 |
| Caucasian-vs-AfricanAmerican |
4.996000E-01 |
| Caucasian-vs-Asian |
7.723600E-01 |
| AfricanAmerican-vs-Asian |
6.759400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.606000E-01 |
| Normal-vs-Female |
2.016400E-01 |
| Male-vs-Female |
1.170160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.289000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.405000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.652200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.736800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.682400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.399800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.742200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.275400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.742600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.685800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.000400E-01 |
| Classical-VS-Follicular |
1.30420119148766E-11 |
| Classical-VS-Other |
8.644100E-02 |
| Classical-VS-Normal |
1.068420E-02 |
| Tall-VS-Follicular |
1.89859999999431E-05 |
| Tall-VS-Other |
6.364100E-02 |
| Tall-VS-Normal |
4.472500E-02 |
| Follicular-VS-Other |
5.992400E-01 |
| Follicular-VS-Normal |
8.162000E-04 |
| Other-VS-Normal |
3.208400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.418000E-01 |
| Normal-vs-N1 |
7.380400E-01 |
| N0-vs-N1 |
9.147400E-01 |
|
|
